149 related articles for article (PubMed ID: 38274928)
1. A Case of Primary Central Nervous System Lymphoma That Developed in a Patient Receiving Fingolimod Therapy for Multiple Sclerosis.
Takanashi K; Fukami S; Akimoto J; Matsubayashi J; Kohno M
Cureus; 2023 Dec; 15(12):e51108. PubMed ID: 38274928
[TBL] [Abstract][Full Text] [Related]
2. Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod.
Morillos MB; de Aguiar PHP; Franceschini PR; Duarte JÁ; Piccini CD; Finkelsztejn A
Neurol Sci; 2023 Jan; 44(1):361-363. PubMed ID: 36031684
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
Chen T; Liu Y; Wang Y; Chang Q; Wu J; Wang Z; Geng D; Yu JT; Li Y; Li XQ; Chen H; Zhuang D; Li J; Wang B; Jiang T; Lyu L; Song Y; Qiu X; Li W; Lin S; Zhang X; Lu D; Lei J; Chen Y; Mao Y
J Hematol Oncol; 2022 Sep; 15(1):136. PubMed ID: 36176002
[TBL] [Abstract][Full Text] [Related]
5. Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosis.
Chacko JA; Strati P; Stout PW; Archer RL; Baltz BP; Chacko JG
Mult Scler Relat Disord; 2021 Apr; 49():102776. PubMed ID: 33508568
[TBL] [Abstract][Full Text] [Related]
6. A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient.
DeRon N; Ahmed M; Lopez D; Alobaidi A
Cureus; 2022 Apr; 14(4):e23858. PubMed ID: 35530884
[TBL] [Abstract][Full Text] [Related]
7. [Primary cutaneous CD30+ T-cell lymphoproliferation during treatment with fingolimod: Case report and literature review].
Cesbron E; Monfort JB; Giannesini C; Duriez P; Moguelet P; Senet P; Francès C; Barbaud A; Chasset F
Ann Dermatol Venereol; 2018; 145(6-7):433-438. PubMed ID: 29673751
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod for relapsing-remitting multiple sclerosis.
La Mantia L; Tramacere I; Firwana B; Pacchetti I; Palumbo R; Filippini G
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009371. PubMed ID: 27091121
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma with preceding spontaneous pseudotumoral demyelination in an immunocompetent adult patient: A case report and literature review.
Yamamoto J; Shimajiri S; Nakano Y; Nishizawa S
Oncol Lett; 2014 Jun; 7(6):1835-1838. PubMed ID: 24932243
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod.
Manouchehri N; Mirmosayyeb O; Badihian S; Shaygannejad V
Mult Scler Relat Disord; 2018 Jan; 19():121-123. PubMed ID: 29195114
[TBL] [Abstract][Full Text] [Related]
11. Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis.
Nitsan Z; Kucuk N; Appel S; Tichmanovich N; Osherov M; Milo R
J Clin Neurosci; 2018 Feb; 48():102-103. PubMed ID: 29108666
[TBL] [Abstract][Full Text] [Related]
12. [A case of multiple sclerosis with a tumefactive lesion during long-term treatment with fingolimod, leading to decompressive craniotomy].
Shiraishi W; Miyata T; Matsuyoshi A; Yamada Y; Hatano T; Hashimoto T
Rinsho Shinkeigaku; 2023 Jan; 63(1):37-44. PubMed ID: 36567105
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma in a patient with neuropsychiatric systemic lupus erythematosus receiving mycophenolate mofetil: A case report and literature review.
Sakairi T; Nakasatomi M; Watanabe M; Hamatani H; Ikeuchi H; Kaneko Y; Handa H; Hiromura K
Mod Rheumatol Case Rep; 2022 Jan; 6(1):36-40. PubMed ID: 34505624
[TBL] [Abstract][Full Text] [Related]
14. Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment.
Hatcher SE; Waubant E; Nourbakhsh B; Crabtree-Hartman E; Graves JS
JAMA Neurol; 2016 Jul; 73(7):790-4. PubMed ID: 27135594
[TBL] [Abstract][Full Text] [Related]
15. Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Papathemeli D; Gräfe R; Hildebrandt U; Zettl UK; Ulrich J
Mult Scler; 2016 Dec; 22(14):1888-1890. PubMed ID: 27207455
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
Ohe Y; Hayashi T; Mishima K; Nishikawa R; Sasaki A; Matsuda H; Uchino A; Tanahashi N
Intern Med; 2013; 52(4):483-8. PubMed ID: 23411706
[TBL] [Abstract][Full Text] [Related]
17. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report.
Ma S; Sen SS; Jug R; Zhang X; Zhang WL; Shen S; Yu CQ; Xu HT; Yang LH; Wang E
Medicine (Baltimore); 2018 Sep; 97(38):e12482. PubMed ID: 30235749
[TBL] [Abstract][Full Text] [Related]
18. Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case.
Wirdah A; Djamaludin N; Syahrir M; Andayani YD; Andriani M; Diansari Y
Acta Med Indones; 2023 Jan; 55(1):107-109. PubMed ID: 36999259
[TBL] [Abstract][Full Text] [Related]
19. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Samaraweera AP; Cohen SN; Akay EM; Evangelou N
Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
[TBL] [Abstract][Full Text] [Related]
20. CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
Tu S; Zhou X; Guo Z; Huang R; Yue C; He Y; Li M; Chen Y; Liu Y; Chang LJ; Li Y
Front Oncol; 2019; 9():1350. PubMed ID: 31867275
[No Abstract] [Full Text] [Related]
[Next] [New Search]